InvestorsHub Logo
Followers 32
Posts 12692
Boards Moderated 0
Alias Born 08/29/2012

Re: meshcan post# 387181

Tuesday, 09/05/2023 4:47:20 AM

Tuesday, September 05, 2023 4:47:20 AM

Post# of 402271
Not sure what your point is.

This has been posted on this board a dozen+ times already.

The U.S. Food and Drug Administration had said on Monday it has approved generic versions of Vyvanse from 11 drugmakers after Takeda's exclusivity over the drug expired on Aug. 24. Copycats of the drug come in capsules and chewable tablets, ranging between 10 milligrams to 70 milligram doses.

https://www.reuters.com/business/healthcare-pharmaceuticals/generic-drugmakers-start-shipping-copies-takedas-adhd-drug-vyvanse-2023-08-31/

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-multiple-generics-adhd-and-bed-treatment

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News